Floatz logo

Dextromethorphan

Pseudobulbar Affect (PBA)

Avanir PharmaceuticalsSmall moleculePhase 4 / ApprovedDormant
BBB
75/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
62/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Pseudobulbar Affect (PBA) cohort.

Asset / SponsorPhaseRating
QUINIDINE SULFATE HYDRATE
Avanir Pharmaceuticals
Phase 3BB

Same molecule, other indications

Dextromethorphan is also rated in:

stroke disorderDormant
BBB
Indicative ·
73 / 100
View asset →
traumatic brain injuryDormant
BB
Indicative ·
69 / 100
View asset →
major depressive disorderDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →